Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

Organon

Status and phase: Completed; Phase 3

Conditions: Hypertriglyceridemia; Hypercholesterolemia

Treatments: Drug: Comparator: fenofibrate monotherapy; Drug: MK0653, ezetimibe

Study type: Interventional

Funder types: Industry

Identifiers

NCT00092560

2004_035

0653-036

Details and patient eligibility

About

The purpose of this study is to evaluate the cholesterol lowering effectiveness and safety of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).

Full description

The duration of treatment is 18 weeks.

Enrollment: 587 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• High cholesterol and high triglycerides

Exclusion criteria

• Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study